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Abstract
Background: Saccharomyces cerevisiae is widely utilized in basic research as a model eukaryotic
organism and in biotechnology as a host for heterologous protein production. Both activities
demand the use of highly regulated systems, able to provide accurate control of gene expression
in functional analysis, and timely recombinant protein synthesis during fermentative production.
The tightly regulated GAL1-10 promoter is commonly used. However, induction of the GAL system
requires the presence of the rather expensive inducer galactose and the absence of glucose in the
culture media. An alternative to regulate transcription driven by GAL promoters, free of general
metabolic changes, is the incorporation of the hybrid Gal4-ER-VP16 protein developed by D.
Picard. This chimeric protein provides galactose-independent activation of transcription from GAL
promoters in response to β-estradiol, even in the presence of glucose. However, constitutive
expression of this transactivator results in relatively high basal activity of the GAL promoters,
therefore limiting the gene expression capacity that is required for a number of applications.
Results: In order to improve this expression tool, we have introduced additional regulatory
elements allowing a simultaneous control of both the abundance and the intrinsic activity of the
Gal4-ER-VP16 chimeric transactivator. The most efficient combination was obtained by placing the
coding sequence of the hybrid activator under the control of the GAL1  promoter. This
configuration results in an amplification feedback loop that is triggered by the hormone, and
ultimately leads to the enhanced regulation of recombinant genes when these are also driven by a
GAL1 promoter. The basal expression level of this system is as low as that of native GAL-driven
genes in glucose-containing media.
Conclusion: The feedback regulatory loop that we have engineered allows a 250-fold induction
of the regulated gene, without increasing the basal activity of the target promoter, and achieving a
12-fold higher regulation efficiency than the previous configuration.
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Background
Recombinant DNA expression constitutes a major
approach in gene function studies that naturally comple-
ment genetic and genomic research. Well-regulated
expression systems provide an invaluable tool to investi-
gate the cellular roles of novel genes, either in their origi-
nal cellular environment, or in specialized host
organisms. Thus, these systems can be utilized to observe
the biological effects of the controlled expression (or lack
of it) of a given DNA sequence. Very often they also pro-
vide the means to produce and purify a desired gene prod-
uct, opening the way to the comprehensive analysis and
manufacture of proteins of biotechnological interest.
S. cerevisiae has been widely employed as a host organism
in the expression of heterologous proteins [1-7], using
regulated systems developed to allow low basal, highly
inducible protein production. In this sense, timely expres-
sion during fermentation is important to prevent a prema-
ture metabolic burden and any possible toxic effect
throughout the culture growing-phase that might lead to
a reduction in protein yields, or to genetic instability.
Yeast-derived transcriptional promoters used in the above
mentioned systems are, along with others, those of the
MET3  gene, negatively regulated by the amino acid
methionine [8], the PHO5 gene, negatively regulated by
inorganic phosphate [9], the CUP1  gene, activated by
Cu2+ ions [10], and the GAL1 and GAL10 genes, activated
by galactose and repressed by glucose [11,12]. Other yeast
systems designed for tightly regulated gene expression
incorporate transcriptional elements derived from bacte-
ria, like those inducible or repressible by tetracycline (Tet-
Off and Tet-On) [13,14].
Expression systems based on the GAL1-10 promoter are
among the strongest ones [15]. Under natural conditions,
expression of the GAL1 and GAL10 genes depends on the
product of the GAL4 gene, which activates the GAL1-10
promoter in the presence of galactose and the absence of
glucose [16], a major disadvantage when the metabolic
changes associated to this switch in carbon source are rel-
evant to the study. In addition, the high cost of the
inducer can preclude scaling up production of a commer-
cially valuable protein using this system. A good alterna-
tive to regulate transcription driven by GAL promoters is
the incorporation of the hybrid protein developed by D.
Picard and co-workers, a chimerical transcriptional activa-
tor that combines the DNA binding domain of Gal4 with
the hormone binding domain of human estrogen recep-
tor and the transactivation domain of the herpex virus
protein VP16 [17]. This system permits the β-estradiol-
inducible expression of recombinant genes placed under
the control of GAL promoters, in a manner that is inde-
pendent of the presence or absence of galactose or glu-
cose. The system is virtually independent of media
formulation and avoids undesired physiological changes
associated with carbon source switch, but the constitutive
expression of the chimeric transactivator produces
increased basal activities of the target promoters. The
reported effects of the transactivator on the basal activity
of GAL promoters range between 2.3- [18] and 11.4-fold
[17]. In this report we describe an improved yeast expres-
sion platform based on the system described by Louvion
et al [17]. This improvement relies on linked regulatory
cascades or positive feedback loops that amplify the acti-
vating signal of the inducer molecule. Both the cascade
and the loop modulate simultaneously the abundance of
the transactivator and its intrinsic activity, resulting in
low-basal, highly inducible gene expression systems.
Results and Discussion
A native GAL promoter does not eliminate the basal 
increase produced by Gal4-ER-VP16
In order to explore possible ways to improve the efficiency
of the yeast estrogen-regulated system described by Lou-
vion et al [17], we first tested if the high basal activity lev-
els reported by these authors were due to the use of
artificial GAL promoters, combining a number of Gal UAS
fused to the CYC1 TATA sequences. To this end, we meas-
ured the effect of a constitutive Gal4-ER-VP16 transactiva-
tor on the expression of a reporter gene (lacZ), placed
under the control of a native GAL1  promoter, in the
absence of β-estradiol. We found that the constitutive
Gal4-ER-VP16 [17] produced a 13.3-fold increase in the
activity of the native GAL1 promoter (Fig 1A). Addition of
β-estradiol to the culture medium produced a further
32.4-fold increase in the activity of the native GAL1 pro-
moter (Fig 1A), this induction being weaker than that
reported by Louvion et al. for the artificial GAL promoters
(between 100 and 200-fold) [17]. Therefore, a native GAL
promoter would not improve the regulation capacity of
an expression system based on the Gal4-ER-VP16 protein.
An estradiol-induced transcriptional cascade
We investigated the possibility of linking the Gal4-ER-
VP16-regulated system upstream to a second, β-estradiol-
dependent expression system. As this second system we
chose a GAL1 promoter-driven human estrogen receptor
(ER) and a target reporter for this transactivator (ERE-
lacZ), consisting of a minimal CYC1 promoter fused to
three estrogen-responsive elements (ERE) and driving lacZ
transcription. The combination of the GAL1pr-controlled
ER with the constitutively expressed Gal4-ER-VP16 would
produce a transcriptional cascade that should be active
only in the presence of hormone. Its final activator (ER) is
controlled by β-estradiol, at both its expression level and
its transactivator activity (Fig 2A). As shown in Fig. 1B, in
the presence of galactose the GAL1pr-ER/ERE-lacZ system
alone showed very low activation when 1 μM β-estradiol
was added (3.2-fold induction). This is a poor inductionMicrobial Cell Factories 2007, 6:10 http://www.microbialcellfactories.com/content/6/1/10
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value, in comparison to previous studies of ER-dependent
regulation in yeast [19-22], probably due to the high
intrinsic activity of the ERE-lacZ reporter. However, com-
bination of the GAL1pr-ER/ERE-lacZ system with the con-
stitutively expressed Gal4-ER-VP16 in the "cascade-like"
configuration resulted in a β-estradiol-inducible system
with a reduced basal increase and an improved (23.2-
fold) induction level. The induction time courses of the
combined  ADH1pr-Gal4-ER-VP16/GAL1pr-ER/ERE-lacZ
system in glucose plus β-estradiol and the GAL1pr-ER/
ERE-lacZ  in galactose were similar (Fig 3A), indicating
that the higher complexity of the cascade system does not
involve a slower response. The cascade induction reached
a plateau 10–12 hours after the addition of the hormone
(Fig 3B).
The global efficiency of a regulated expression system
depends on both the induction level and the increase in
basal activity of the target promoter due to the presence of
its associated activator. In order to compare the different
systems tested we introduced a new parameter, called reg-
ulation efficiency, obtained as the ratio between the induc-
tion level and the increase in basal activity observed with
each system. Thus, the system composed by the constitu-
tively expressed ADH1pr-Gal4-ER-VP16 transactivator
and the GAL1 promoter showed a regulation efficiency of
Hormone-dependent regulation of β-galactosidase by the different systems analysed in this work Figure 1
Hormone-dependent regulation of β-galactosidase by the different systems analysed in this work. β-galactosidase 
activities (Miller units) of W303-1A (A, B, C) or BY4741 (D) cells containing the following plasmids: (A) p416GAL1-lacZ and 
pHCA/GAL4(1-93)ERVP16; (B) pVitBx2 and pGAL1-ER; or pVitBx2, pGAL1-ER and pHCA/GAL4(1-93)ERVP16; (C) 
p416GAL1-lacZ and p414GAL1-GAL4ERVP16; (D) p416GAL1-lacZ and p415GAL1-GAL4ERVP16. All cultures were grown in 
the presence of glucose except when "gal" is written, indicating galactose-containing cultures. In all cases, 5 ml cultures were 
inoculated from a mid-log preculture to an O.D. (600 nm) of 0.02, and incubated for 14 hours at 30°C in the presence or the 
absence of 1 μM β-estradiol. Average and standard deviation of at least three independent experiments are represented. 
Induction represents the ratio between β-galactosidase activities (in the presence and in the absence of β-estradiol). Basal 
increase was calculated dividing the β-galactosidase activity detected in the absence of hormone, by the activity exhibited by 
cells cultured in the same conditions, containing the same target reporter construct, but lacking any estrogen-dependent trans-
activator. Regulation efficiency was calculated dividing induction by basal increase.Microbial Cell Factories 2007, 6:10 http://www.microbialcellfactories.com/content/6/1/10
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2.4. A similarly low value was exhibited by the GAL1pr-
ER/ERE-lacZ  system for β-estradiol in the presence of
galactose. In contrast, the ADH1pr-Gal4-ER-VP16/
GAL1pr-ER/ERE-lacZ  system showed a regulation effi-
ciency of 38.7, indicating that the sequential action of two
regulators is more convenient when an accurate regula-
tion is needed. This improved regulation resulted from
the combination of a higher induction level (23.2-fold)
with a slight reduction of the basal activity of the ERE-lacZ
reporter (0.6-fold). However, according to the values
reported by Louvion et al., the regulation efficiency of
their system ranged between 11.0 and 40.5 [17]. We there-
fore conclude that the transcriptional cascade assembled
in these studies, although resulting in a moderately low
basal activity of the target promoter, does not significantly
improve the regulation efficiency of the original Gal4-ER-
VP16-dependent system.
An estradiol-triggered self-induced regulatory loop
As an alternative approach, and in order to prevent the
increase in basal activity of GAL promoters produced by
the constitutive expression of Gal4-ER-VP16, we placed
the transcription of this chimeric transactivator under the
control of a GAL1  promoter. The resulting system,
designed as a self-inducible regulatory loop triggered by β-
estradiol is depicted in Fig 2B. First, we measured the
expression of a GAL1pr-lacZ  reporter construct in cells
containing this regulatory loop in the absence of estrogen,
finding no increase in the basal activity of the GAL1 pro-
moter, but rather a small decrease (Fig 1C). When these
Synoptic explanation of the two estrogen-induced regulatory systems described in this work Figure 2
Synoptic explanation of the two estrogen-induced regulatory systems described in this work. A. β-estradiol-
induced transcriptional cascade. B. β-estradiol-triggered self-induced regulatory loop. Boxes indicate coding regions; arrows 
indicate activation.
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cells were cultured in the presence of 1 μM β-estradiol, we
measured a 247.5-fold induction of lacZ  expression.
Although the overall maximal activity was 3.5-fold higher
when the activator was constitutively expressed (Fig
1A,C), the induction of the loop exceeded the highest
induction level reported by Louvion et al. [17] and it was
7 times higher than that produced by the constitutively
expressed Gal4-ER-VP16 system on the same target pro-
moter (Fig 1A).
Considering altogether the small reduction in basal activ-
ity and the considerable induction level observed, the
resulting regulation efficiency of the self-inducing system
was very high (495.0). Although the basal activities of the
Induction time-course of the estrogen-dependent transcriptional cascade and of the estradiol-triggered regulatory loop Figure 3
Induction time-course of the estrogen-dependent transcriptional cascade and of the estradiol-triggered regu-
latory loop. A. 25 ml glucose selective medium were inoculated with W303-1A yeast cells, containing plasmids pVitBx2, 
pHCA/GAL4(1-93)ERVP16 and pGAL1-ER. A similar volume of galactose selective medium was inoculated with yeast cells 
containing plasmids pVitBx2 and pGAL1-ER. After adding 1 μM β-estradiol (solved in ethanol), or similar amounts of ethanol, 
samples were taken at the indicated time points and assayed for β-galactosidase (Miller units). A representative experiment is 
shown. B. 24 hours time-course of W303-1A yeast cells, containing the cascade system (plasmids pVitBx2, pHCA/GAL4(1-
93)ERVP16 and pGAL1-ER) after adding 1 μM β-estradiol, compared with W303-1A yeast cells containing the loop system 
(plasmids p416GAL1-lacZ and p414GAL1-GAL4ERVP16) after adding two different hormone conentration (1 μM and 50 nM). 
The experiments were performed as in A. To facilitate comparison, the results were represented as the percentage of the 
maximal values reached by each culture, except for the loop 50 nM estradiol, wich was referred to the maximal value of the 
loop culture containing 1 μM estradiol. A representative experiment is shown.
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loop system are close to zero, and therefore this number
should be considered cautiously, it represents one order
of magnitude higher than the values found for the consti-
tutively expressed Gal4-ER-VP16 system or the transcrip-
tional cascade described above. The tighter regulation of
this loop system involved an exponential kinetic of induc-
tion rather than linear kinetic shown by the cascade sys-
tem, as indicated by the induction time-courses shown in
Fig 3B. However, both the cascade and the loop systems
reached the maximal induction 10–12 hours after adding
the hormone (Fig 3B).
The high efficiency of this regulatory loop is not restricted
to the W303 yeast genetic background. When we intro-
duced the GAL1pr-GAL4ERVP16/GAL1pr-lacZ system in
an S288C-derivative strain (BY4741), similar induction
levels (246-fold) and regulation efficiency (176) were
obtained (Fig 1D). Moreover, in the S288C background
the maximal activities were higher than in W303 (Fig
1C,D).
In order to characterize the loop system further, we inves-
tigated its dependence on Gal4 and Gal80, the two spe-
cific regulators of the GAL1 promoter. As shown in Fig 1D,
the absence of the Gal4 activator did not affect signifi-
cantly either the basal or the induced levels. In the absence
of the Gal80 repressor, the basal activity of the GAL1 pro-
moter was increased, as could be expected. Again the loop
system caused a significant induction in this background
(Fig 1D). These results suggest that the loop system can be
Hormone-dependence and switch-off time course of the β-estradiol-triggered self-induced regulatory loop Figure 4
Hormone-dependence and switch-off time course of the β-estradiol-triggered self-induced regulatory loop. 5 
ml glucose cultures of W303-1A cells containing plasmids p416GAL1-lacZ and p414GAL1-GAL4ERVP16 were inoculated as in 
Fig 1 and grown for 14 hours in the presence of the indicated concentration of β-estradiol and assayed for β-galactosidase. The 
average and standard deviation of three different experiments is represented. B. 100 ml glucose medium were inoculated with 
yeast cells containing plasmids p416GAL1-lacZ and p414GAL1-GAL4ERVP16 and grown until stationary phase (19 h) in the 
presence of 50 nM estradiol. Cells were then washed three times by centrifugation and used to inoculate a new 100 ml culture 
lacking β-estradiol, at a OD(600 nm) of 0.2. Seven hours later (arrow) cells were washed again and used to inoculate a new cul-
ture at a OD(600 nm) of 0.2. As a control, a 100 ml glucose culture was inoculated at a OD(600 nm) of 0.2, from a saturated 
preculture grown in galactose. Samples were taken at the indicated times and assayed for β-galactosidase activity. A represent-
ative experiment is shown
0
20
40
60
80
100
120
log [ß-estradiol] (M)
ß
-
g
a
l
a
c
t
o
s
i
d
a
s
e
 
(
%
)
-10 -8 -6 -5 -7 -9
0
20
40
60
80
100
120
0 5 10 15 20 25 30
Time (h)
ß
-
g
a
l
a
c
t
o
s
i
d
a
s
e
 
(
%
)
Loop switch-off
GAL1pr-lacZ gal-glu
A
BMicrobial Cell Factories 2007, 6:10 http://www.microbialcellfactories.com/content/6/1/10
Page 7 of 9
(page number not for citation purposes)
easily adapted to other eukaryotic cells lacking the Gal4
and Gal80 regulators.
We also measured the hormone dose-response of the loop
system. The levels obtained after culturing the yeast cells
with increasing concentrations of estradiol are shown in
Fig 4A. Maximal induction was observed at about 1 μM
and the half-maximal response at 0.05 μM. These values
are one order of magnitude higher than those reported for
the constitutively expressed Gal4-ER-VP16 system [17]
and for the hormone-dependence of ER in yeast [19,21].
In fact, the dose response of the loop system does not
show the typical sharp increase of hormone receptors,
suggesting that the self-induced loop facilitates to obtain
intermediate levels of expression. Moreover, the time
course of the induction at sub-optimal hormone concen-
tration (50 nM) also indicated an exponential kinetic, but
at this ligand concentration the loop system reached the
plateau 2–4 hours earlier than the culture activated with 1
μM hormone (Fig 3B).
We also tested if the active loop could be switched-off by
removing β-estradiol from the medium. As shown in Fig
4B, five hours and two cell duplications after removing
the hormone, cells retained nearly 70% of the β-galacosi-
dase activity. A new reinoculation and eight more hours
were needed to reduce the β-galactosidase activity below
10% of the initial values. The comparison with the switch-
off of a galactose-activated GAL1pr::lacZ, by transferring
the cells from galactose to glucose, rules-out that the slow
inactivation of the loop might be due to the high stability
of β-galactosidase (Fig 4B). One possible explanation for
these results is that the residual amounts of estradiol
remaining inside the cell were sufficient to maintain the
activation of the system. An alternative explanation might
be that, once the regulatory loop has been triggered, the
system remains epigenetically active without needing
additional inputs. In any case, this characteristic of the
system makes it suitable for regulating gene expression in
those industrial applications requiring the absence of β-
estradiol in the final product. In this study we have tested
two new regulation strategies: a transcriptional cascade
and a feed back regulatory loop. In both cases we have
obtained very low levels of increase in basal activity and
considerable levels of induction, especially in the feed
back loop. Both systems share a basic feature: the inducer
acts on the transactivator simultaneously at two levels: its
intrinsic activity and its abundance. We believe that this
scheme can be used to improve the regulation capacity of
other expression systems, whose regulators produce high
basal activity of the target promoters.
Conclusion
The coordinated control of the expression of an estrogen-
responsive transcriptional activator with its intrinsic acti-
vation amplifies synergistically the regulatory capacity of
the target promoter.
The transcriptional cascade described in this work, com-
posed by a constitutively expressed Gal4-ER-VP16 transac-
tivator and a GAL1pr-driven estrogen receptor, does not
increase the basal activity of the ERE-containing target
promoter, maintaining the regulation efficiency of the
previous system.
The self-induced regulatory loop that we have engineered
allows a 250-fold induction of the regulated gene, without
increasing the basal activity of the target promoter. The
global regulation efficiency of this feed back loop exceeds
the estrogen-induced expression systems that have been
previously designed for yeast cells. Its hormone-depend-
ence, more gradual than the one usually exhibited by
nuclear receptors, allows intermediate levels of regula-
tion. The loop system does not depend on the specific reg-
ulators of the GAL1 promoter, facilitating its adaptation to
other eukaryotic environments.
Methods
Strain and plasmids
The yeast strains used in this study were W303-1A (MATa
ade2-1 can1-100 his3-11, 15 leu2-3,112 trp1-1 ura3-1) [23]
BY4741 (MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0) [24] and
the gal4Δ and gal80Δ derivative of BY4741 conserved in
the EUROSCARF collection.
Table 1: Plasmids used in this work
Plasmid Relevant features Reference
p416GAL1-lacZ URA3, CEN, GAL1pr::lacZ [26]
pHCA/GAL4(1-93)ERVP16 HIS3, CEN, ADH1pr::GAL4ERVP16 [17]
pVitBx2 URA3, CEN, ERE-CYC1pr::lacZ [30]
pGAL1-ER LEU2, CEN, GAL1pr::ER This study
p414GAL1-GAL4ERVP16 TRP1, CEN,GAL1pr::GAL4ERVP16 This study
p415GAL1-GAL4ERVP16 LEU2, CEN,GAL1pr::GAL4ERVP16 This study
pP6HEG0 human ER [25]
pRS415 LEU2, CEN [27]
p414GAL1 TRP1, CEN, GAL1pr [26]Microbial Cell Factories 2007, 6:10 http://www.microbialcellfactories.com/content/6/1/10
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All plasmids used in this study were centromeric and are
described in Table 1. Plasmid pGAL1-ER was constructed
by inserting a 2.1 kb BamHI DNA fragment from plasmid
pP6HEG0 [25], containing the cDNA of human estrogen
receptor, into the BamHI site present in p414GAL1 [26],
immediately downstream from the GAL1 promoter. Plas-
mid p414GAL1-GAL4ERVP16 was constructed by insert-
ing a 1,5 kb PCR fragment (oligos
ATGAAGCTACTGTCTTCTATCGA and TCACTATAG-
GGCGAATTGG) from pHCA/GAL4(1-93)ERVP16,
encoding the chimeric transactivator GAL4ERVP16 [17],
into pGEMT-easy (Promega), generating pGEMT-
GAL4ERVP16. A 1.5 kb SpeI fragment from this plasmid
was inserted into the SpeI site present in p414GAL1 [26],
immediately downstream from the GAL1 promoter. Plas-
mid p415GAL1-GAL4ERVP16 was constructed by ligating
the 2.6 kb PvuII fragment from p414GAL1-GAL4ERVP16
to the bigest PvuII fragment of pRS415 [27].
Yeast transformation was carried out using standard
methods [28]. Transformants were routinely assayed for
plasmid stability, by replica-plating after non-selective
culturing. Those transformants containing more than one
plasmid did not show abnormal levels of plasmid insta-
bility.
Culture conditions
Yeast transformants were cultured at 30°C in complete
synthetic medium, with 2% glucose or 2% galactose as the
carbon source [28]. Liquid cultures were incubated in
orbital shakers at 120 rpm. β-estradiol (SIGMA E-1024-
1G) was added when indicated from a 2.5 mM stock solu-
tion in ethanol. Equivalent amounts of ethanol were
added to control cultures.
β-galactosidase assays
β-galactosidase assays were performed as described previ-
ously [29] using a cell-permeabilization method [28].
Activities were calculated as Miller units. Yeast strains con-
taining reporters alone were assayed in the presence of
empty expression vectors. Experiments were performed at
least three times, although in figures representing time-
course experiments only one is shown. In all cases the rep-
licate produced similar results.
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